Compass Therapeutics, Inc.

CMPX

CMPXCompass Therapeutics, Inc. US flag

NASDAQ Capital Market

2.24

USD

-0.03

- -

309.07MMarket Cap

Income Statement (USD)

API ChatGPT

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -	- -	- -	- -	- -	1	- -
+ Sales & Services Revenue	- -	- -	- -	- -	- -	- -	1	- -
- Cost of Revenue	- -	- -	- -	- -	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -	- -	- -	-1	- -
- Operating Expenses	38	34	28	31	42	50	57	73
+ Selling, General & Admin	11	12	13	11	12	12	15	17
+ Research & Development	27	22	15	20	30	38	42	56
+ Other Operating Expense	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	-38	-34	-28	-31	-42	-50	-57	-73
- Non-Operating (Income) Loss	- -	1	2	51	-2	-8	-7	-6
+ Interest Expense, Net	- -	- -	1	- -	-2	-8	-7	-6
+ Interest Expense	1	1	1	- -	- -	- -	- -	- -
- Interest Income	1	1	- -	- -	2	8	7	6
+ Other Non-Op (Income) Loss	- -	- -	1	51	- -	- -	- -	- -
Pretax Income	-38	-35	-29	-82	-39	-42	-49	-66
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-38	-35	-30	-82	-39	-42	-49	-66
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-38	-35	-30	-82	-39	-42	-49	-66
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-38	-35	-30	-82	-39	-42	-49	-66
- Preferred Dividends	- -	- -	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-38	-35	-30	-82	-39	-42	-49	-66
EBIT	-38	-34	-28	-31	-42	-50	-57	-73
EBITDA	-36	-32	-25	-30	-40	-48	-55	-71
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	-6,455.53	- -
EBITA	-38	-34	-28	-31	-42	-50	-57	-73
Gross Margin (%)	- -	- -	- -	- -	- -	- -	100	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	-6,661.76	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	-5,808.82	- -
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -
Depreciation Expense	2	2	2	2	2	2	2	1
Basic Weighted Avg Shares	52	52	31	63	105	127	137	158
Basic EPS, GAAP	-0.73	-0.67	-0.96	-1.31	-0.37	-0.33	-0.36	-0.42
Basic EPS from Cont Ops	-0.73	-0.67	-0.96	-1.31	-0.37	-0.33	-0.36	-0.42
Diluted Weighted Avg Shares	52	52	31	63	105	127	137	158
Diluted EPS, GAAP	-0.73	-0.67	-0.96	-1.31	-0.37	-0.33	-0.36	-0.42
Diluted EPS from Cont Ops	-0.73	-0.67	-0.96	-1.31	-0.37	-0.33	-0.36	-0.42

Balance Sheet (USD)

API ChatGPT

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Current Assets	59	26	50	147	195	154	133	210
+ Cash, Cash Equivalents & STI	58	25	47	145	187	152	127	209
+ Cash & Cash Equivalents	58	25	47	145	35	24	43	31
+ ST Investments	- -	- -	- -	- -	152	128	83	178
+ Accounts & Notes Receiv	- -	- -	- -	- -	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Assets	1	1	3	3	8	1	6	1
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	6	4	2	7	5	3	8	10
+ Property, Plant & Equip, Net	5	4	1	6	5	3	7	9
+ Property, Plant & Equip	9	10	7	11	10	9	13	16
- Accumulated Depreciation	4	6	6	5	6	6	6	7
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	- -	1	- -	- -	- -	1	1
+ Total Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	1	- -	- -	- -	1	1
Total Assets	65	30	52	154	200	157	140	220
+ Payables & Accruals	3	2	2	8	14	5	6	10
+ Accounts Payable	2	1	1	1	3	4	2	2
+ Accrued Taxes	1	1	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	1	1	1	7	10	1	3	9
+ ST Debt	4	6	7	1	1	1	- -	1
+ ST Borrowings	4	6	7	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	1	1	1	- -	1
+ Other ST Liabilities	2	2	1	2	2	2	3	3
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	2	2	1	2	2	2	3	3
Total Current Liabilities	8	10	10	11	16	8	9	14
+ LT Debt	11	9	2	3	2	1	6	9
+ LT Borrowings	11	9	2	- -	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	3	2	1	6	9
+ Other LT Liabilities	130	130	- -	- -	- -	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	130	130	- -	- -	- -	- -	- -	- -
Total Noncurrent Liabilities	141	139	2	3	2	1	6	9
Total Liabilities	149	149	12	14	18	8	15	23
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	2	3	191	374	455	464	490	628
+ Common Stock	2	- -	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	- -	3	191	374	455	464	490	628
- Treasury Stock	- -	- -	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-87	-122	-151	-234	-273	-315	-365	-431
+ Other Equity	- -	- -	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	-85	-119	40	140	182	149	125	197
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -
Total Equity	-85	-119	40	140	182	149	125	197
Total Liabilities & Equity	65	30	52	154	200	157	140	220
Shares Outstanding	61	61	51	101	126	128	138	178
Number of Employees	- -	- -	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	4	3	2	7	10
Net Debt	-43	-10	-38	-145	-35	-24	-43	-31
Net Debt to Equity	50.44	8.8	-94.48	-103.17	-19.24	-16.31	-34.72	-15.57
Tangible Common Equity Ratio	-131.18	-390.39	76.95	91.1	90.98	94.69	89.2	89.62
Current Ratio	6.96	2.67	4.97	13.84	12.05	19.73	14.96	15.02
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

+ Net Income	-38	-35	-30	-82	-39	-42	-49	-66
+ Depreciation & Amortization	2	2	2	2	2	2	2	1
+ Non-Cash Items	1	1	4	55	4	3	7	7
+ Stock-Based Compensation	1	1	4	4	5	6	9	8
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	51	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	- -	- -	-1	-3	-2	-2
+ Chg in Non-Cash Work Cap	2	- -	-4	6	-1	-3	-4	9
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	-2	1	-6	7	-5	5
+ Inc (Dec) in Accts Payable	2	-1	-1	7	5	-8	2	4
+ Inc (Dec) in Other	- -	- -	- -	-1	-1	-1	-1	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-34	-32	-27	-20	-34	-41	-45	-49
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	-2	- -	- -	-2	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	-2	- -	- -	-2	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	60	128	76	3	18	138
+ Increase in Capital Stock	- -	- -	60	128	76	3	18	138
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -	-151	27	47	-93
+ Dec in LT Investment	- -	- -	- -	- -	49	182	135	101
+ Inc in LT Investment	- -	- -	- -	- -	-200	-155	-88	-195
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	-2	- -	- -	-2	-151	27	47	-93
+ Dividends Paid	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	15	- -	-6	-9	- -	- -	- -	- -
+ Cash From Debt	15	- -	- -	- -	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	-6	-9	- -	- -	- -	- -
+ Other Financing Activities	49	- -	-6	- -	- -	- -	-1	-8
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	64	- -	49	119	76	3	17	130
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -	- -	- -
Net Changes in Cash	28	-32	22	97	-110	-11	19	-13
EBITDA	-36	-32	-25	-30	-40	-48	-55	-71
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	-6,455.53	- -
Free Cash Flow	-36	-32	-27	-21	-34	-41	-45	-49
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-32	-32	-30	-34	-41	-45	-49
Free Cash Flow per Basic Share	-0.69	-0.62	-0.87	-0.34	-0.33	-0.32	-0.33	-0.31
Price/Free Cash Flow	- -	- -	- -	-11.01	-15.6	-4.88	-4.44	-17.24
Cash Flow to Net Income	0.88	0.91	0.91	0.24	0.87	0.96	0.91	0.74
Capital Expenditures	-2	- -	- -	-2	- -	- -	- -	- -